Advancing Cancer Diagnostics: Technologies for Quantifying the Particle Concentration of Extracellular Vesicles in...

Extracellular vesicles (EVs) have emerged as pivotal mediators in cancer biology, offering unprecedented opportunities for early detection and real-time disease monitoring. These nanoscale cargo carriers, which mirror the molecular signature of their parental cells, are increasingly recognized as potential biomarkers in oncology. Notably, tumor cells release EVs in significantly greater quantities than in physiological conditions, making EV particle concentration measurement a promising frontier in cancer diagnostics. Despite the surge of interest, current EV quantification methods remain limited by the nanoscale size, heterogeneity, and complex physicochemical properties of EV populations. This review presents a comprehensive evaluation of the latest technological advances in quantifying EV particle concentration, highlighting their operational principles, advantages, and key limitations. Special attention is given to strategies that exploit EV size, optical properties, and surface protein markers - core features leveraged in state-of-the-art assays. By synthesizing breakthroughs and identifying challenges, this review aims to drive innovation in the field. Ultimately, it is argued that developing accurate, scalable, and clinically adaptable EV particle quantification platforms is not only essential but transformative for the next generation of non-invasive cancer diagnostics. This overview will serve as a valuable resource for researchers aiming to accelerate the translation of EV-based technologies into impactful clinical applications.